Lista de obras - Caroline H Williams-Gray

A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease

artículo científico publicado en 2018

A new biomarker for Parkinson's disease?

artículo científico publicado en 2015

Abnormalities of age-related T cell senescence in Parkinson's disease.

artículo científico publicado en 2018

Addenbrooke's Cognitive Examination-Revised for mild cognitive impairment in Parkinson's disease.

artículo científico publicado en 2012

Associations between Lifestyle Factors and Parkinson's Disease in an Urban Sri Lankan Clinic Study.

artículo científico publicado en 2017

BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease.

artículo científico publicado en 2008

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease

artículo científico publicado en 2007

Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.

artículo científico publicado en 2010

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention

artículo científico publicado en 2016

Comparative epidemiology of incident Parkinson's disease in Cambridgeshire, UK.

artículo científico publicado en 2016

DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits

artículo científico publicado en 2019

Development and external validation of a prognostic model in newly diagnosed Parkinson disease

artículo científico publicado en 2016

Differences in the Presentation and Progression of Parkinson's Disease by Sex

artículo científico publicado en 2020

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

artículo científico publicado en 2007

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts

artículo científico publicado en 2019

Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease

artículo científico publicado en 2020

Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts

scientific article published on 10 September 2019

Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.

artículo científico publicado en 2013

Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease

scientific article published on 16 May 2019

Investigation of TGFB2 as a candidate gene in multiple sclerosis and Parkinson’s disease

article

Mild cognitive impairment and Parkinson's disease--something to remember.

artículo científico publicado en 2014

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

artículo científico publicado en 2010

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis

artículo científico publicado en 2018

No alterations in α-synuclein gene dosage observed in sporadic Parkinson's disease

article

No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening.

artículo científico publicado en 2006

Parkinson disease: Defining PD subtypes - a step toward personalized management?

artículo científico publicado en 2017

Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition

artículo científico publicado en 2008

Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease

scientific article published on 05 November 2018

Prefrontal Dopamine Levels Determine the Balance between Cognitive Stability and Flexibility ⬇️

artículo científico publicado el 20 de febrero de 2012

Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.

artículo científico publicado en 2006

Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson's Disease Cohort (ICICLE-PD)

artículo científico publicado en 2020

Putative cortical dopamine levels affect cortical recruitment during planning.

artículo científico publicado en 2013

Review: The spectrum of clinical features seen with alpha synuclein pathology.

artículo científico publicado en 2016

Saccadic latency distributions in Parkinson's disease and the effects of L-dopa

artículo científico publicado en 2006

Seeing Is Believing: Alpha-Synuclein Oligomers in Parkinson's Disease Brain.

artículo científico publicado en 2015

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).

artículo científico publicado en 2016

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease

artículo científico publicado en 2017

Targeting aged astrocytes may be a new therapeutic strategy in Parkinson's disease.

artículo científico publicado en 2018

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

artículo científico publicado en 2013

The Endotoxin Hypothesis of Parkinson's Disease

artículo científico publicado en 2023

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease

artículo científico publicado en 2016

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease

scientific article published on 20 November 2018

The clinical heterogeneity of Parkinson's disease and its therapeutic implications

scientific article published on 14 October 2018

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

artículo científico

The motor and cognitive features of Parkinson's disease in patients with concurrent Gaucher disease over 2 years: a case series.

artículo científico publicado en 2018

The natural history of treated Parkinson's disease in an incident, community based cohort

artículo científico

The spectrum of cognitive impairment in Lewy body diseases

artículo científico publicado en 2014

The utility of the Cambridge Behavioural Inventory in neurodegenerative disease.

artículo científico publicado en 2007

The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease

artículo científico publicado en 2008

Timing Is Everything: The T-Cell Response to α-Synuclein Is Maximal in Early Parkinson's

scientific article published on 19 June 2020

Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies

scientific article published on 02 July 2019

Visual hallucinations predict increased benefits from rivastigmine in Parkinson's disease dementia.

artículo científico publicado en 2007

Which patients with Parkinson's disease participate in clinical trials? One centre's experiences with a new cell based therapy trial (TRANSEURO).

artículo científico publicado en 2014

α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function.

artículo científico publicado en 2016

Lista de obras de Caroline H Williams-Gray

A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease

A new biomarker for Parkinson's disease?

Abnormalities of age-related T cell senescence in Parkinson's disease.

Addenbrooke's Cognitive Examination-Revised for mild cognitive impairment in Parkinson's disease.

Associations between Lifestyle Factors and Parkinson's Disease in an Urban Sri Lankan Clinic Study.

BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease.

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease

Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention

Comparative epidemiology of incident Parkinson's disease in Cambridgeshire, UK.

DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits

Development and external validation of a prognostic model in newly diagnosed Parkinson disease

Differences in the Presentation and Progression of Parkinson's Disease by Sex

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts

Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease

Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts

Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.

Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease

Investigation of TGFB2 as a candidate gene in multiple sclerosis and Parkinson’s disease

Mild cognitive impairment and Parkinson's disease--something to remember.

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis

No alterations in α-synuclein gene dosage observed in sporadic Parkinson's disease

No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening.

Parkinson disease: Defining PD subtypes - a step toward personalized management?

Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition

Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease

Prefrontal Dopamine Levels Determine the Balance between Cognitive Stability and Flexibility ⬇️

Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.

Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson's Disease Cohort (ICICLE-PD)

Putative cortical dopamine levels affect cortical recruitment during planning.

Review: The spectrum of clinical features seen with alpha synuclein pathology.

Saccadic latency distributions in Parkinson's disease and the effects of L-dopa

Seeing Is Believing: Alpha-Synuclein Oligomers in Parkinson's Disease Brain.

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease

Targeting aged astrocytes may be a new therapeutic strategy in Parkinson's disease.

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

The Endotoxin Hypothesis of Parkinson's Disease

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease

The clinical heterogeneity of Parkinson's disease and its therapeutic implications

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

The motor and cognitive features of Parkinson's disease in patients with concurrent Gaucher disease over 2 years: a case series.

The natural history of treated Parkinson's disease in an incident, community based cohort

The spectrum of cognitive impairment in Lewy body diseases

The utility of the Cambridge Behavioural Inventory in neurodegenerative disease.

The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease

Timing Is Everything: The T-Cell Response to α-Synuclein Is Maximal in Early Parkinson's

Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies

Visual hallucinations predict increased benefits from rivastigmine in Parkinson's disease dementia.

Which patients with Parkinson's disease participate in clinical trials? One centre's experiences with a new cell based therapy trial (TRANSEURO).

α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function.